General Information of Drug (ID: DMLATOQ)

Drug Name
BAY1129980
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
D00ZVM

References

1 ClinicalTrials.gov (NCT02134197) Dose-escalation Study of BAY1129980. U.S. National Institutes of Health.